A
2.42
-0.09 (-3.40%)
| Penutupan Terdahulu | 2.50 |
| Buka | 2.45 |
| Jumlah Dagangan | 63,414 |
| Purata Dagangan (3B) | 254,276 |
| Modal Pasaran | 65,379,120 |
| Harga / Buku (P/B) | 0.490 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2025 |
| EPS Cair (TTM) | -2.30 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.01% |
| Nisbah Semasa (MRQ) | 22.53 |
| Aliran Tunai Operasi (OCF TTM) | -53.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -39.36 M |
| Pulangan Atas Aset (ROA TTM) | -22.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Alto Neuroscience, Inc. | Menurun | Menurun |
AISkor Stockmoo
-1.0
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.00 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 7.48% |
| % Dimiliki oleh Institusi | 77.52% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Alpha Wave Global, Lp | 31 Mar 2025 | 3,707,757 |
| Armistice Capital, Llc | 31 Mar 2025 | 1,600,000 |
| Point72 Asset Management, L.P. | 31 Mar 2025 | 1,240,053 |
| Vestal Point Capital, Lp | 31 Mar 2025 | 915,000 |
| Awm Investment Company, Inc. | 31 Mar 2025 | 901,984 |
| 72 Investment Holdings, Llc | 31 Mar 2025 | 667,778 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 10.00 (HC Wainwright & Co., 314.08%) | Beli |
| Median | 7.00 (189.86%) | |
| Rendah | 4.00 (Wedbush, 65.63%) | Pegang |
| Purata | 7.00 (189.86%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 2.35 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 15 May 2025 | 4.00 (65.63%) | Pegang | 2.43 |
| HC Wainwright & Co. | 07 Apr 2025 | 10.00 (314.08%) | Beli | 2.26 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |